What is the FDA warning for montelukast?
Montelukast (a prescription medicine for asthma and allergy-related symptoms) carries an FDA warning about serious neuropsychiatric side effects. The FDA requires a boxed warning because some patients have reported behavior and mood changes, including agitation, depression, sleep problems, and suicidal thoughts or actions [1].
What kinds of symptoms are included in the warning?
The warning highlights potentially severe mental health and behavior changes such as:
- agitation or aggression
- depression
- abnormal dreams or sleep disruption
- hallucinations
- suicidal thoughts or behavior [1]
Why did the FDA issue the warning?
The FDA’s action was based on reports of neuropsychiatric events in patients taking montelukast, including serious outcomes such as suicidal ideation or behavior [1].
Which patients should be especially cautious?
The FDA warns that montelukast can cause these effects in some people, and the risk is not limited to one age group. The boxed warning also reflects the FDA’s concern that these symptoms can be serious, so clinicians and patients need to discuss risks before starting therapy and to monitor closely after starting [1].
When is montelukast commonly used despite the warning?
Montelukast is still used to prevent and treat asthma symptoms and to manage allergy-related conditions such as seasonal allergies. However, because of the boxed warning, clinicians typically weigh whether the benefits are worth the neuropsychiatric risk, especially for milder allergy indications where other options may be available [1].
What should you do if side effects show up?
If someone taking montelukast develops mood or behavior changes, sleep disturbances, or thoughts of self-harm, the FDA warning directs prompt medical attention. Patients should contact their prescriber right away rather than waiting for symptoms to resolve [1].
Do generics of montelukast have the same FDA warning?
Yes. The FDA warning applies to the drug class/molecule, so it carries over to generic montelukast products as well. The boxed warning is part of the labeling for montelukast [1].
Sources
- https://www.fda.gov/ (FDA safety/boxed warning information for montelukast; FDA label-based safety communication)